Duncan Gregory Scott 4
4 · Virios Therapeutics, Inc. · Filed Jun 22, 2021
Insider Transaction Report
Form 4
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2021-06-21+60,000→ 60,000 totalExercise: $6.78Exp: 2031-06-21→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The stock option vests one-third on June 21, 2022 and 1/24th monthly thereafter.